Back

Comparative procedural outcomes of pulsed field, cryoballoon, and radiofrequency ablation for paroxysmal atrial fibrillation: a 15-year single-centre experience

12 April 2026 (14:30 - 15:05)
Organised by: Logo
Congress Presentation Part of: Outcome of atrial fibrillation cryoablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Noor Muhammad Azlan Shah Atan

National Heart Institute, Kuala Lumpur (Malaysia)

4 More presentations in this session

Presentation thumbnail
Three-year follow-up of atrial fibrillation burden reduction after cryoballoon pulmonary vein isolation in early persistent atrial fibrillation: results from the COOL-PER trial
Doctor S. Han (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Single-shot ablation for AF: real-world procedural and one-year outcomes with the newly adopted PulseSelect PFA compared with cryoballoon from the 1STOP project
Professor G. Boriani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Timing of early recurrence predicts long-term outcomes after cryoballoon pulmonary vein isolation
Associate Professor A. Baimbetov (Almaty, KZ)
Abstract Slides Video
Presentation thumbnail
Very high-power short-duration ablation vs. cryoballoon for paroxysmal atrial fibrillation: a prospective single-center study with one-year follow- up
Doctor D. Debreceni (Pecs, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Outcome of atrial fibrillation cryoablation

The Event

Event poster

EHRA 2026

12 April 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Multicenter propensity score-matched comparison of Farapulse, cryoballoon, and radiofrequency ablation for paroxysmal atrial fibrillation with 2-year follow-up
thumbnail
Congress Presentation
Comparison of pulsed field and radiofrequency ablation for non-paroxysmal atrial fibrillation: a propensity score-matched analysis
thumbnail
Congress Presentation
Comparison of pulsed field ablation and radiofrequency for persistent atrial fibrillation: a monocentric observational study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources